Regulus Therapeutics Inc. (38) | Uncategorized (8)

Recent Contracts

Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019 (Filed With SEC on March 9, 2021)
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020 (Filed With SEC on March 9, 2021)
Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada (Filed With SEC on July 30, 2019)
Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc (Filed With SEC on March 18, 2019)